These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 20665634)
1. Prion protein and Abeta-related synaptic toxicity impairment. Calella AM; Farinelli M; Nuvolone M; Mirante O; Moos R; Falsig J; Mansuy IM; Aguzzi A EMBO Mol Med; 2010 Aug; 2(8):306-14. PubMed ID: 20665634 [TBL] [Abstract][Full Text] [Related]
2. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475 [TBL] [Abstract][Full Text] [Related]
3. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172 [TBL] [Abstract][Full Text] [Related]
4. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology. Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309 [TBL] [Abstract][Full Text] [Related]
5. Synaptic changes in Alzheimer's disease and its models. Pozueta J; Lefort R; Shelanski ML Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952 [TBL] [Abstract][Full Text] [Related]
6. Prion protein in Alzheimer's pathogenesis: a hot and controversial issue. Benilova I; De Strooper B EMBO Mol Med; 2010 Aug; 2(8):289-90. PubMed ID: 20698011 [TBL] [Abstract][Full Text] [Related]
7. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers. Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975 [TBL] [Abstract][Full Text] [Related]
8. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875 [TBL] [Abstract][Full Text] [Related]
10. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease. Armstrong RA; Lantos PL; Cairns NJ Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834 [TBL] [Abstract][Full Text] [Related]
11. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981 [TBL] [Abstract][Full Text] [Related]
12. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466 [TBL] [Abstract][Full Text] [Related]
14. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology. Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423 [TBL] [Abstract][Full Text] [Related]
15. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP. Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243 [TBL] [Abstract][Full Text] [Related]
17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210 [TBL] [Abstract][Full Text] [Related]
18. Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. Tampellini D; Capetillo-Zarate E; Dumont M; Huang Z; Yu F; Lin MT; Gouras GK J Neurosci; 2010 Oct; 30(43):14299-304. PubMed ID: 20980585 [TBL] [Abstract][Full Text] [Related]
19. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease. Balietti M; Giorgetti B; Casoli T; Solazzi M; Tamagnini F; Burattini C; Aicardi G; Fattoretti P J Alzheimers Dis; 2013; 34(4):887-96. PubMed ID: 23313923 [TBL] [Abstract][Full Text] [Related]
20. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models. Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]